Merck Cholesterol Trial Can Continue
Wednesday, March 13, 2013 - 01:10
in Health & Medicine
An independent monitor told the company it could proceed with a large clinical trial of Vytorin, Merck said.
Updated by artificial intelligence Sat, 3 Jan 2026, 15:40:35 UTC Learn more
- Tell your friends
- Get science news via